3657 Short-term continence outcomes in men over 75 undergoing robotic-assisted radical prostatectomy
Abstract Introduction As the incidence of prostate cancer rises with increasing life expectancy, more men over the age of 75 are candidates for curative treatment. Robotic-assisted radical prostatectomy (RARP) is commonly used in younger populations, but data on postoperative continence outcomes in older patients remain limited. Objective To evaluate short-term urinary continence outcomes in men aged ≥75 years undergoing RARP at a high-volume UK centre. Methods A retrospective analysis was performed on 36 men aged 75 or older who underwent RARP between June 2018 and June 2021. Continence was assessed using the ICIQ-SF questionnaire and pad usage at multiple postoperative time points up to 12 months. Continence was defined as the use of zero pads per day. Results At 12 months postoperatively, 63.9% of patients were fully continent (zero pads), and 19.4% used one safety pad daily, yielding an overall functional continence rate of 83.3%. Continence improved progressively over time, consistent with the gradual recovery process observed in this age group. Conclusions RARP appears to be a viable surgical option for carefully selected men over 75, offering favourable continence outcomes at one year postoperatively. Chronological age alone should not be a contraindication for RARP, and geriatric assessment tools may aid in patient selection. Larger, prospective studies are warranted to confirm these findings.
Authors
- V.R.M. Kusuma (ORCID: https://orcid.org/0000-0003-3870-0734)
- Sabina Dranova (ORCID: https://orcid.org/0000-0002-6799-5351)
- D D Carbin
- D Papanikolaoua
- W A Chedid
- C Eden
- D Moschonas
- K Patil
- J Hicks
- M Perry
Institutions
- Aristotle University of Thessaloniki (GR)
- Royal Surrey County Hospital (GB)
Publication Details
- Journal
- Age and Ageing
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1093/ageing/afaf368.140
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00